Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SJ733 and Tafenoquine for P. Vivax Malaria
NCT07430592Phase 2Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SJ-733 in malaria. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
SJ-733
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07430592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07430592.